reports 
Fierce Pharma
APRIL 16, 2024
For the first time, Johnson & Johnson has reported sales numbers for its novel multiple myeloma treatment Tecvayli and they indicate that the bispecific, which was approved in October 2022, is | For the first time, Johnson & Johnson is reporting sales of its multiple myeloma drug Tecvayli, which is off to a strong launch and contributing to (..)
Fierce Pharma
JULY 11, 2023
Moderna has lodged two new lawsuits at the High Court in Dublin, Ireland, and the Brussels Commercial Court in Belgium, Juve Patent first reported. Caught in a litigation crossfire, Moderna has reportedly opened two new fronts in its COVID-19 vaccine patent war with Pfizer and BioNTech.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MARCH 26, 2024
Bluebird bio reported progress of its launch of three gene therapies and said it will have to refile financial statements because of accounting errors
Fierce Pharma
JUNE 20, 2023
But the company is hitting back at the recent news report. AstraZeneca, the largest multinational pharma company in China, has reportedly made plans to separate its local business there in case geopolitical tensions worsen. |
Advertiser: ZoomInfo
This report aims to highlight the current state of B2B database and contact acquisition strategies and organizations’ goals to leverage data to fuel their go-to-market strategies in 2020 and beyond. As buyer expectations to receive this type of relevant engagement continues to heighten, database management strategies are of high importance.
Fierce Pharma
OCTOBER 6, 2023
The survey follows a June report which found that nearly all centers had short supply of the chemotherapies. While the White House recently touted the FDA’s efforts to mitigate the ongoin | The National Comprehensive Cancer Network found that 72% of centers are still experiencing a carboplatin shortage, while 59% remain low on cisplatin.
Fierce Pharma
JANUARY 4, 2024
billion claim after it was victimized by a crippling cyberattack in 2017, Bloomberg Law reports. Merck has reportedly settled with insurance companies that contested the pharma giant’s $1.4 billion claim after it was victimized by a crippling cyberattack in 2017. Merck has settled with insurance companies that contested the pharma giant’s $1.4
Advertiser: ZoomInfo
Those implementing a B2B sales and marketing intelligence solution reported that they have realized 35% more leads in their pipeline and 45% higher-quality leads leading to higher revenue and growth. However, organizations are fighting back - and winning.
Advertiser: ZoomInfo
In a recent survey with Demand Gen Report, we found 59% of experienced practitioners (those with ABM programs more than a year old) indicated their ABM programs are meeting or greatly exceeding their expectations, while only 45% of novices (those with ABM programs less than one year old) could say the same.
Advertiser: ZoomInfo
This report shows how each provider measures up and helps B2B marketing professionals select the right one for their needs.
Advertiser: ZoomInfo
To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and promote omnichannel marketing.
Advertiser: ZoomInfo
Download the report today to discover more! In 2022, as companies continue to move more functions online, employees will take a more virtual -- and flexible -- mindset and lifestyle in parallel to the digitization of businesses. To succeed, you must change the way you conceive and build new products as a digital business.
Advertiser: ZoomInfo
According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.
Advertiser: ZoomInfo
Review, report, and iterate. In this eBook, you’ll discover how to improve your demand generation program—and your bottom line—in four data-driven steps: Nail down your ideal customer profile (ICP). Leverage intent data. Personalize messages to your priority accounts. And much more!
Advertiser: ZoomInfo
However, if lead generation, reporting, and measuring ROI is important to your marketing team, then data normalization matters - a lot. Data normalization. It’s not a far stretch to suggest that the topic isn’t exactly what gets marketers excited in their day-to-day workflow.
Expert insights. Personalized for you.
198 
Let's personalize your content